relation: http://repositorio.uneatlantico.es/id/eprint/584/ canonical: http://repositorio.uneatlantico.es/id/eprint/584/ title: A gliclazide complex based on palladium towards Alzheimer's disease: promising protective activity against Aβ-induced toxicity in C. elegans creator: García-García, Amalia creator: Rojas, Sara creator: Rivas-García, Lorenzo creator: Navarro-Hortal, María D. creator: Romero-Márquez, Jose M. creator: Fernández-Bolaños, José G. creator: Choquesillo-Lazarte, Duane creator: Salinas-Castillo, Alfonso creator: López, Óscar creator: Quiles, José L. creator: Rodríguez-Diéguez, Antonio subject: Biomedicina description: A new palladium coordination compound based on gliclazide with the chemical formula [Pd(glz)2] (where glz = gliclazide) has been synthesized and characterised. The structural characterization reveals that this material consists of mononuclear units formed by a Pd2+ ion coordinated to two molecules of the glz ligand, in which palladium ions exhibit a distorted plane-square coordination sphere. This novel material behaves like a good and selective inhibitor of butyrylcholinesterase, one of the most relevant therapeutic targets against Alzheimer's disease. Analysis of the enzyme kinetics showed a mixed mode of inhibition, the title compound being capable of interacting with both the free enzyme and the enzyme-substrate complex. Finally, the palladium compound shows promising protective activity against Aβ-induced toxicity in the Caenorhabditis elegans model, which has never been reported. date: 2022-02 type: Artículo type: PeerReviewed format: text language: en rights: cc_by_nc_4 identifier: http://repositorio.uneatlantico.es/id/eprint/584/1/d1cc04404d.pdf identifier: Artículo Materias > Biomedicina Universidad Europea del Atlántico > Investigación > Producción Científica Abierto Inglés A new palladium coordination compound based on gliclazide with the chemical formula [Pd(glz)2] (where glz = gliclazide) has been synthesized and characterised. The structural characterization reveals that this material consists of mononuclear units formed by a Pd2+ ion coordinated to two molecules of the glz ligand, in which palladium ions exhibit a distorted plane-square coordination sphere. This novel material behaves like a good and selective inhibitor of butyrylcholinesterase, one of the most relevant therapeutic targets against Alzheimer's disease. Analysis of the enzyme kinetics showed a mixed mode of inhibition, the title compound being capable of interacting with both the free enzyme and the enzyme-substrate complex. Finally, the palladium compound shows promising protective activity against Aβ-induced toxicity in the Caenorhabditis elegans model, which has never been reported. metadata García-García, Amalia; Rojas, Sara; Rivas-García, Lorenzo; Navarro-Hortal, María D.; Romero-Márquez, Jose M.; Fernández-Bolaños, José G.; Choquesillo-Lazarte, Duane; Salinas-Castillo, Alfonso; López, Óscar; Quiles, José L. y Rodríguez-Diéguez, Antonio mail SIN ESPECIFICAR, SIN ESPECIFICAR, SIN ESPECIFICAR, SIN ESPECIFICAR, SIN ESPECIFICAR, SIN ESPECIFICAR, SIN ESPECIFICAR, SIN ESPECIFICAR, SIN ESPECIFICAR, jose.quiles@uneatlantico.es, SIN ESPECIFICAR (2022) A gliclazide complex based on palladium towards Alzheimer's disease: promising protective activity against Aβ-induced toxicity in C. elegans. Chemical Communications, 58 (10). pp. 1514-1517. ISSN 1359-7345 relation: http://doi.org/10.1039/d1cc04404d relation: doi:10.1039/d1cc04404d language: en